一月 2026
- Home
- BioIVT
一月 2026的BioIVT市场份额分析
advance your research with our wide range of human and animal biospecimens. our biospecimen samples are readily available and can be customized for you.
BioIVT(包含公司地区分支机构)
查看更多网站流量和参与度信息- bioivt.com
BioIVT收入截至 一月 2026为 25M - 50M
BioIVT主要域名产生的收入
3 年中BioIVT主要域名的收入
BioIVT主要域名的收入
BioIVT热门域名的总访问量
了解BioIVT市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
子公司明细
BioIVT热门域名的平均访问时长
分析BioIVT参与度指标。
过去 3 个月的平均访问时长
子公司明细
BioIVT热门域名的平均页面浏览量
了解BioIVT如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
子公司明细
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
BioIVT 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻BioIVT, LLC hired Auro Nair as Chief Executive Officer on Feb 2nd '26.BioIVT, the leading biospecimen solutions provider and global research partner for drug and diagnostic development, today announced the appointment of Dr. Auro Nair as the company's Chief Executive Officer.
二月 2, 2026阅读更多
新闻BioIVT, LLC acquired Cytesbiotech on Nov 4th '25.BALTIMORE, November 04, 2025-(BUSINESS WIRE)-BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the acquisition of BeCytes Biotechnologies, a Barcelona, Spain-based company specializing in the coordination of the collection, processing and distribution of high-quality human tissues and cells for biomedical research.
十一月 4, 2025阅读更多
新闻BioIVT, LLC attended event 2025 Cell & Gene Meeting on Oct 2nd '25.BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced it will showcase its broad portfolio of cellular solutions at several leading industry events focused on cell and gene therapy innovation, including the 2025 Cell & Gene Meeting on the Mesa.
十月 2, 2025阅读更多
查看 BioIVT 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。